However, I feel strongly that people need to be informed about both the risks, benefits, and limitations of this (or any) medication that they use, which is part of the informed consent process between you and the prescribing professional
There was a Phase 2 trial that got published in The New England Journal of Medicine
Bjrnholm KD, Skovsted GF, Mitgaard-Thomsen A, Rakipovski G, Tveden-Nyborg P, Lykkesfeldt J, Povlsen GK
Obesity medication lorcaserin activates brainstem GLP-1 neurons to reduce food intake and augments GLP-1 receptor agonist induced appetite suppression
Strategies to Increase GLP-1 Digestion of specific nutrients leads to GLP-1 secretion from L-cells located in the lining of the small intestine
Applied Microbiology